Annual number of lung cancer deaths potentially avertable by screening in the United States

Cancer

Volumn 119, Issue 7, 2013, Pages 1381-1385

  Ma, Jiemin ^a   Ward, Elizabeth M ^a   Smith, Robert ^a   Jemal, Ahmedin ^a  

^a AMERICAN CANCER SOCIETY   (United States)

Author keywords

avertable death; low dose computed tomography; lung cancer; mortality; screening

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER MORTALITY; CANCER SCREENING; CLINICAL STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH SURVEY; HUMAN; LOW DOSE COMPUTED TOMOGRAPHY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SEX; SEX DIFFERENCE; SMOKING; UNITED STATES;

AGED; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; SMOKING; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES;

EID: 84875382483     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27813     Document Type: Article

References (20)

1. National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365: 395-409.
2. Howden LM, Meyer JA,. Age and Sex Composition: 2010 2011. Available at: census.gov/prod/cen2010/briefs/c2010br-03.pdf. Accessed September 25, 2011.
3. Centers for Disease Control and Prevention. About the National Health Interview Survey. Available at: cdc.gov/nchs/nhis/about-nhis.htm. Accessed September 27, 2011.
4. Centers for Disease Control and Prevention. About the National Health and Nutrition Examination Survey. Available at: cdc.gov/nchs/nhanes/about-nhanes. htm. Accessed September 27, 2011.
5. Centers for Disease Control and Prevention. NHIS Linked Mortality Files. Available at: cdc.gov/nchs/data-access/data-linkage/mortality/nhis-linkage.htm. Accessed September 27, 2011.
6. Centers for Disease Control and Prevention. NHANES III Linked Mortality File. Available at: cdc.gov/nchs/data-access/data-linkage/mortality/nhanes3- linkage.htm. Accessed September 27, 2011.
7. Bach PB, Mirkin JN, Oliver TK, et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA. 2012; 307: 2418-2429.
8. Lopes Pegna A, Picozzi G, Mascalchi M, et al. ITALUNG Study Research Group. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer. 2009; 64: 34-40.
9. Pedersen JH, Ashraf H, Dirksen A, et al. The Danish randomized lung cancer CT screening trial-overall design and results of the prevalence round. J Thorac Oncol. 2009; 4: 608-614.
10. Baldwin DR, Duffy SW, Wald NJ, Page R, Hansell DM, Field JK,. UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer. Thorax. 2011; 66: 308-313.
11. Goulart BH, Bensink ME, Mummy DG, Ramsey SD,. Lung cancer screening with low-dose computed tomography: costs, national expenditures, and cost-effectiveness. J Natl Compr Canc Netw. 2012; 10: 267-275.
12. Mahadevia PJ, Fleisher LA, Frick KD, Eng J, Goodman SN, Powe NR,. Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis. JAMA. 2003; 289: 313-322.
13. Manser R, Dalton A, Carter R, Byrnes G, Elwood M, Campbell DA,. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting. Lung Cancer. 2005; 48: 171-185.
14. McMahon PM, Kong CY, Bouzan C, et al. Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol. 2011; 6: 1841-1848.
15. Pyenson BS, Sander MS, Jiang Y, Kahn H, Mulshine JL,. An actuarial analysis shows that offering lung cancer screening as an insurance benefit would save lives at relatively low cost. Health Aff (Millwood). 2012; 31: 770-779.
16. Wisnivesky JP, Mushlin AI, Sicherman N, Henschke C,. The cost-effectiveness of low-dose CT screening for lung cancer: preliminary results of baseline screening. Chest. 2003; 124: 614-621.
17. Humphrey LL, Teutsch S, Johnson M,; U.S. Preventive Services Task Force. Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2004; 140: 740-753.
18. Oken MM, Hocking WG, Kvale PA, et al. PLCO Project Team. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA. 2011; 306: 1865-1873.
19. Altekruse SF, Kosary CL, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2007. Bethesda, MD: National Cancer Institute; based on November 2009 SEER data submission, posted to the SEER web site, 2010.
20. Centers for Disease Control and Prevention (CDC). Cancer screening-United States, 2010. MMWR Morb Mortal Wkly Rep. 2012; 61: 41-45.